Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
LY3214996 + Abemaciclib for Cancer
Recruiting1 awardPhase 2
Indianapolis, Indiana
This trial is testing a combination of drugs to see if they are effective in treating cancer. The trial will continue until the cancer progresses, the patient has major side effects, or the patient withdraws from the trial.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.